Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates
- 1 December 2006
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 86 (6) , 1682-1687
- https://doi.org/10.1016/j.fertnstert.2006.05.049
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndromeHuman Reproduction, 2005
- GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized studyHuman Reproduction, 2005
- Luteinizing hormone supplementation increases pregnancy rates in gonadotropin-releasing hormone antagonist donor cyclesFertility and Sterility, 2004
- Impact of the gonadotropin-releasing hormone antagonist in oocyte donation cyclesFertility and Sterility, 2003
- Lower levels of inhibin A and pro-αC during the luteal phase after triggering oocyte maturation with a gonadotropin-releasing hormone agonist versus human chorionic gonadotropinFertility and Sterility, 2003
- Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: Short communicationHuman Reproduction, 2000
- Comparative Analysis of the Effects of Gonadotropin-Releasing Hormone Agonist on the Proliferative Activity, Apoptosis, and Steroidogenesis in Cultured Porcine Granulosa Cells at Varying Stages of Follicular GrowthEndocrine, 2000
- Effects of GnRH on Protein Kinase C Activity, Ca2+ Mobilization and Steroidogenesis of Human Granulosa Cells.Endocrine Journal, 1998
- Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 g), GnRH agonist (buserelin, 500 g) and human chorionic gonadotrophin (10 000 IU)Human Reproduction, 1995
- Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyteThe Lancet, 1992